STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
82
13F, latest reported quarter
What the filings say about ARX
Insiders, 180 days
-$20.9M net sold
5 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$6.8M
5 notices
Accelerant insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Accelerant Holdings insiders sold a net $20.9M of stock across 36 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Dec 8, 2025.
The trade is 2.6% of the 20,868 shares held after it.
4 other insiders sold within 30 days.
82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Meriwether Karen Sue sold about $10.6K of ARX on Aug 21, 2026; 4 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Jun 23, 2026.
The trade is 1.5% of the 1,341,834 shares held after it.
4 other insiders sold within 30 days.
82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hasley Nancy sold about $400.8K of ARX on Aug 13, 2026; 4 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
10 earlier Form 4 trades (code P or S) here by this insider (1 buy, 9 sales), the last on Aug 10, 2026.
The trade is 1.4% of the 6,369,290 shares held after it.
4 other insiders sold within 30 days.
82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Co-Founder, Chief U/W Officer ONeill Francis James sold about $1.1M of ARX on Aug 11, 2026; 4 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
10 earlier Form 4 trades (code P or S) here by this insider (1 buy, 9 sales), the last on Aug 3, 2026.
The trade is 0.3% of the 27,591,939 shares held after it.
4 other insiders sold within 30 days.
82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Co-Founder, CEO RADKE JEFFREY L sold about $967.1K of ARX on Aug 10, 2026; 4 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
9 earlier Form 4 trades (code P or S) here by this insider (1 buy, 8 sales), the last on Jul 28, 2026.
The trade is 1.0% of the 6,458,509 shares held after it.
4 other insiders sold within 30 days.
82 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Co-Founder, Chief U/W Officer ONeill Francis James sold about $767.7K of ARX on Aug 10, 2026; 4 other insiders sold within 30 days and 82 funds added in the latest 13F quarter.
36 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
ARX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
KAREN MERIWETHER
Filed 2026-08-21
$10.6K
NANCY HASLEY
Filed 2026-08-13
$278.9K
RADKE JEFFREY L
Filed 2026-08-10
$958.8K
Francis James O'Neill
Filed 2026-08-10
$4.6M
RADKE JEFFREY L
Filed 2026-08-03
$956.3K
ARX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Small Cap Value Fund
$24.7M position · as of 2026-06-30
0.8%
American Century Small Cap Value Insights ETF
$91.0K position · as of 2026-05-31
0.7%
AVIP AB Small Cap Portfolio
$808.2K position · as of 2026-06-30
0.3%
YORKTOWN GROWTH FUND
$270.9K position · as of 2026-07-31
0.2%
SmallCap Growth Fund I
$3.6M position · as of 2026-07-31
0.1%
SMALL CAP EQUITY FUND
$1.2M position · as of 2026-06-30
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $20.9M sold by insiders over 180 days, 82 funds added last quarter, $6.8M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt ARX
FY Dec 2025
3.67x
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
0.38x
Mar 2026
2.75x
Dec 2025
3.67x
Sep 2025
5.13x
Jun 2025
6.53x
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-241.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ARX
FY Dec 2025
-268.2%
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
-241.6%
Mar 2026
-236.4%
Dec 2025
-268.2%
Sep 2025
-275.5%
Jun 2025
+13.2%
Mar 2025
+6.3%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-15.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ARX
FY Dec 2025
-18.7%
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
-15.6%
Mar 2026
-15.8%
Dec 2025
-18.7%
Sep 2025
-17.0%
Jun 2025
+0.6%
Mar 2025
+0.4%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital ARX
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed ARX
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing ARX
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value ARX
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield ARX
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing ARX
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
ARX ranks highest on growth (90th percentile) and financial health (56th), and lowest on profitability (2nd), among Insurance peers.
Profitability
2
Inputs
Return on equity-241.6% · 0 pct, sector of 116
Return on assets-15.6% · 4 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
56
Inputs
Debt to equity0.17x · 74 pct, sector of 104
Cash flow to debt0.38x · 39 pct, sector of 97
Growth
90
Inputs
Revenue growth, YoY+51.5% · 90 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
7
Inputs
Net Form 4 buying (codes P and S), 180d-$20.9M · 14 pct, sector of 100
Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
30
Inputs
Funds adding, latest quarter82 · 30 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
18
Inputs
Short interest, % of float+7.9% · 18 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ARX filings, in plain words
Are Accelerant insiders buying or selling ARX?
In the 180 days to 2026-10-27, Accelerant insiders were net sellers, a net $20.9M across purchases and sales reported on Form 4, by 5 sellers.
Are there planned insider sales of ARX?
Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $6.8M of stock; the latest, by KAREN MERIWETHER, was filed 2026-08-21.
Read the full summary
In the 180 days to 2026-10-27, Accelerant insiders were net sellers of ARX, a net $20.9M across purchases and sales reported on Form 4 by 5 sellers. None of the 24 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $6.8M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.